Synapse - Works

Results (5608)

Relationship of baseline PSA and degree of PSA decline to radiographic progression-free survival (rPFS) in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302

Meeting Abstract

Ryan, C. J.; Londhe, A.; Molina, A.; Smith, M. R.; De Bono, J. S.; Mulders, P.; Rathkopf, D. E.; Saad, F.; Logothetis, C.; Fizazi, K.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Impact of concomitant bone-targeted therapies (BTT) on outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) without prior chemotherapy (ctx) treated with abiraterone acetate (AA) or prednisone (P)

Meeting Abstract

Saad, F.; Fizazi, K.; Smith, M. R.; Griffin, T. W.; Londhe, A.; Rathkopf, D. E.; Molina, A.; Ryan, C. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Clinical impact of an online tool to guide choice of therapy (Tx) for patients (Pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Quill, T. A.; Rini, B. I.; Jonasch, E.; Bowser, A.; Mortimer, J. A.; Motzer, R. J.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Long-term safety and efficacy analysis of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy (COU-AA-302)

Meeting Abstract

Rathkopf, D. E.; Smith, M. R.; De Bono, J. S.; Logothetis, C.; Shore, N.; De Souza, P. L.; Fizazi, K.; Mulders, P.; Mainwaring, P. N.; Hainsworth, J. D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary HER2 expression data from NeuACT, the phase II randomized, open-label trial of DN24-02 in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Hoffman-Censits, J. H.; Quinn, D. I.; Sharma, P.; DeVries, T.; Chen, M.; Locker, M.; Bajorin, D. F.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II study of neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) chemotherapy in patients with muscle-invasive urothelial cancer (MI-UC): Pathologic and radiologic response, serum tumor markers, and DNA excision repair pathway biomarkers in relation to disease-free survival (DFS)

Meeting Abstract

Qu, A. Q.; Jacobus, S. J.; Signoretti, S.; Stack, E. C.; Krajewski, K. M.; Rosenberg, J. E.; Choueiri, T. K.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Continuation of sunitinib following RECIST progression on first-line sunitinib

Meeting Abstract

Burotto Pichun, M. E.; Wilkerson, J.; Stein, W. D.; Motzer, R. J.; Bates, S. E.; Fojo, T.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT)

Meeting Abstract

Pilewskie, M. L.; Ho, A. Y.; Orell, E.; Stempel, M.; Chen, Y.; Eaton, A.; Patil, S.; Morrow, M.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Safety of radium-223 dichloride (Ra-223) with docetaxel (D) in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium Study

Meeting Abstract

Morris, M. J.; Hammers, H. J.; Sweeney, C.; Antonarakis, E. S.; Cho, S. Y.; Pandit-Taskar, N.; Jacene, H.; Bloma, M.; Aksnes, A. K.; O'Bryan-Tear, C. G.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save